Amphotericin B delivery from bone cement increases with porosity but strength decreases

Clinical Orthopaedics and Related Research

Volumn 469, Issue 11, 2011, Pages 3002-3007

  Kweon, Chris ^a   McLaren, Alex C ^a,b   Leon, Christine ^b   McLemore, Ryan ^a,b  

^a Banner Orthopaedic Residency   (United States)

^b Arizona State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BONE CEMENT; CEFAZOLIN; WATER;

ANALYSIS OF VARIANCE; COMPRESSIVE STRENGTH; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ELUTION; POROSITY; PRIORITY JOURNAL;

EID: 80054720872     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-011-1928-5     Document Type: Conference Paper

References (21)

1. I Astafieva K Khougaz A Eisenberg 1995 Micellization in block polyelectrolyte solutions. 2. Fluorescence study of the critical micelle concentration as a function of soluble block length and salt concentration Macromolecules 28 7127 7134 10.1021/ma00125a015 1:CAS:528:DyaK2MXotVKqsrk%3D
2. B Buranapanitkit K Oungbho N Ingviya 2005 The efficacy of hydroxyapatite composite impregnated with amphotericin B Clin Orthop Relat Res. 437 236 241 16056054 10.1097/01.blo.0000165851.81386.6a
3. J Chandra DM Kuhn PK Mukherjee LL Hoyer T McCormick MA Ghannoum 2001 Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance J Bacteriol. 183 5385 5394 11514524 10.1128/JB.183.18.5385-5394.2001 1:CAS:528:DC%2BD3MXmsFyqtLY%3D
4. N Collette P van der Auwera AP Lopez C Heymans F Meunier 1989 Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate Antimicrob Agents Chemother. 33 362 368 2658785 1:STN:280:DyaL1M3ntFOkug%3D%3D
5. J van Eldere L Joosten V Verhaeghe I Surmont 1996 Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test J Clin Microbiol. 34 842 847 8815094
6. A Göǧüş S Akman SB Göksan E Bozdaǧ 2002 Mechanical strength of antibiotic-impregnated bone cement on Day 0 and Day 15: a biomechanical study with surgical Simplex P and teicoplanin Acta Orthop Traumatol Turc. 36 63 71 12510113
7. B Goss C Lutton P Weinrauch M Jabur G Gillett R Crawford 2007 Elution and mechanical properties of antifungal bone cement J Arthroplasty. 22 902 908 17826283 10.1016/j.arth.2006.09.013
8. AD Hanssen 2005 Local antibiotic delivery vehicles in the treatment of musculoskeletal infection Clin Orthop Relat Res. 437 91 96 16056032 10.1097/01.blo.0000175713.30506.77
9. C Leuner J Dressman 2000 Improving drug solubility for oral delivery using solid dispersions Eur J Pharm Biopharm. 50 47 60 10840192 10.1016/S0939-6411(00)00076-X 1:CAS:528:DC%2BD3cXjslyju7c%3D
10. F Marra GM Robbins BA Masri C Duncan KM Wasan EH Kwong PJ Jewesson 2001 Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans Can J Surg. 44 383 386 11603753 1:STN:280:DC%2BD3MrlslKqsw%3D%3D
11. AC McLaren SG McLaren MK Hickmon 2007 Sucrose, xylitol, and erythritol increase PMMA permeability for depot antibiotics Clin Orthop Relat Res. 461 60 63 17549030 10.1097/BLO.0b013e31811f350d
12. AC McLaren SG McLaren R McLemore BL Vernon 2007 Particle size of fillers affects permeability of polymethylmethacrylate Clin Orthop Relat Res. 461 64 67 17762329 10.1097/BLO.0b013e31811f350d 1:STN:280:DC%2BD2srhsFeqsA%3D%3D
13. AC McLaren SG McLaren M Smeltzer 2006 Xylitol and glycine fillers increase permeability of PMMA to enhance elution of daptomycin Clin Orthop Relat Res. 451 25 28 16906079 10.1097/01.blo.0000229321.53040.a1
14. AC McLaren CL Nelson SG McLaren GR DeClerk 2004 The effect of glycine filler on the elution rate of gentamicin from acrylic bone cement Clin Orthop Relat Res. 427 25 27 15552132 10.1097/01.blo.0000143556.41472.2a
15. R McLaren A McLaren B Vernon 2008 Generic tobramycin elutes from bone cement faster than proprietary tobramycin Clin Orthop Relat Res. 466 1372 1376 18340503 10.1007/s11999-008-0199-2 1:STN:280:DC%2BD1czhtlKrsA%3D%3D
16. M Nugent A McLaren B Vernon R McLemore 2010 Strength of antimicrobial bone cement decreases with increased poragen fraction Clin Orthop Relat Res. 468 2101 2106 20162384 10.1007/s11999-010-1264-1
17. HN Rasyid HC van der Mei HW Frijlink S Soegijoko JR van Horn HJ Busscher D Neut 2009 Concepts for increasing gentamicin release from handmade bone cement beads Acta Orthop. 80 508 513 19916680 10.3109/17453670903389782
18. PI Sealy C Nguyen M Tucci H Benghuzzi JD Cleary 2009 Delivery of antifungal agents using bioactive and nonbioactive bone cements Ann Pharmacother. 43 1606 1615 19755620 10.1345/aph.1M143 1:CAS:528: DC%2BC3cXmtlWnsrk%3D
19. P Tancréde J Barwicz S Jutras I Gruda 1990 The effect of surfactants on the aggregation state of amphotericin B Biochim Biophys Acta. 1030 289 295 2261490 10.1016/0005-2736(90)90305-8
20. G Vandermeulen L Rouxhet A Arien ME Brewster V Préat 2006 Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon- caprolactone-co-trimethylenecarbonate) polymeric micelles Int J Pharm. 309 234 240 16406402 10.1016/j.ijpharm.2005.11.031 1:CAS:528:DC%2BD28XnvVWnsw%3D%3D
21. KM Wasan GA Brazeau A Keyhani AC Hayman G Lopez-Berestein 1993 Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins Antimicrob Agents Chemother. 37 246 250 8452354 1:CAS:528:DyaK3sXhtl2iurk%3D